A Home-based Physical Activity Intervention in Breast Cancer Survivors
Launched by DUDLEY GROUP NHS FOUNDATION TRUST · Mar 31, 2015
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Due to the prevalence of treatment-related health concerns and increased risk of developing metabolic syndrome, recurrence and cardiovascular disease, breast cancer survivors may require diagnostic, therapeutic, supportive or palliative services for many years post-diagnosis. Encouraging breast cancer survivors to adopt a healthy lifestyle post-treatment may reduce the healthcare burden resulting from treatment-related sequelae and improve survival. In particular, higher levels of physical activity (PA) may positively influence some of these side-effects of treatment, enhance quality of lif...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female 18 y and over,
- • Diagnosed with invasive breast cancer (Stage I-III) within two years of enrolment and no evidence, or clinical suspicion, of metastatic disease,
- • Post-surgery and had no surgery planned for the next six months at least,
- • Had fully completed adjuvant therapy (radiotherapy and/or chemotherapy) not including hormonal therapy,
- • No previous malignancy except in the case of ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), basal cell carcinoma or cervical carcinoma in situ, or where the patient has been disease-free for 10 years,
- • No concomitant medical or psychiatric problems that might prevent completion of treatment or follow-up,
- • Willing to be randomised, and willing to maintain contact with the investigators over the six months
- Exclusion Criteria:
- • No evidence of invasive breast cancer (i.e. only pre-invasive disease identified),
- • Previous invasive breast cancer (surgically treated DCIS or LCIS is allowed),
- • Inability to participate in PA because of severe disability (e.g. severe arthritic conditions), psychiatric illness and vulnerable subjects, such as pregnant women.
- • Any other patient where PA was not approved by their oncologist due to the presence of one or more contraindications to exercise in cancer patients.
About Dudley Group Nhs Foundation Trust
The Dudley Group NHS Foundation Trust is a prominent healthcare organization dedicated to delivering high-quality medical services and advancing clinical research. Located in the West Midlands, the Trust encompasses a range of hospitals and community services, fostering a patient-centered approach to care. With a commitment to innovation and evidence-based practice, the Trust actively sponsors clinical trials aimed at enhancing treatment options and improving patient outcomes. Its collaborative environment promotes partnerships with academic institutions and industry stakeholders, ensuring a robust framework for conducting impactful research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ian M Lahart, PhD
Principal Investigator
University of Wolverhampton
Amtul R Carmichael, MD
Study Director
Russells Hall Hopsital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials